ElectromedELMD +1.56%91 FCF Margin % is 17.88% as of Mar. 2026, which is 164% above its 10-year median of 6.76. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.15 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Electromed ranks better than 80.37% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Electromed's Free Cash Flow for the
three
months ended in Mar. 2026 was $3.32 Mil. Electromed's Revenue for the
three
months ended in Mar. 2026 was $18.58 Mil. Therefore, Electromed's FCF Margin % for the quarter that ended in Mar. 2026 was 17.88%.
The historical rank and industry rank for Electromed's FCF Margin % or its related term are showing as below:
ELMD'
s FCF Margin % Range Over the Past 10 Years
Min: -5.31 Med: 6.76 Max: 17.32
Current: 12.96
During the past 13 years, the highest FCF Margin % of Electromed was 17.32%. The lowest was -5.31%. And the median was 6.76%.
ELMD's FCF Margin % is ranked better than 80.37% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs ELMD: 12.96
Electromed FCF Margin % Related Terms
Electromed FCF Margin % Historical Data
* Premium members only.
The historical data trend for Electromed's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Electromed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Electromed's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromed (ELMD) has a FCF Margin % of 17.88% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Electromed and its competitors. This is 164% above median its historical median of 6.76. According to the industry distribution chart, Electromed ranks #160 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 19.6%.
Is Electromed's FCF Margin % too high?
Electromed's current FCF Margin % of 17.88% is 164% above median its 10-year median of 6.76. Based on the distribution chart, Electromed ranks #160 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's FCF Margin % compare to MASS and SI?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #160 out of 815 companies for FCF Margin %. This places Electromed in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Electromed and its competitors. Electromed's current FCF Margin % is 17.88%, which is 164% above median its own 10-year median of 6.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.15, compared to a current price of $39.73 — trading 58% above its estimated fair value. The current FCF Margin % is 17.88%, which is 164% above median its 10-year median of 6.76. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Electromed (ELMD), the current FCF Margin % is 17.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $39.73 is trading 58% above its estimated GF Value™ of $25.15.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
FCF Margin %: 17.88% (164% above median its 10-year median of 6.76)
GF Value™: $25.15 vs. price of $39.73 (58% above fair value)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score
Get the complete analysis for ELMD
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
